Psyllid ID: psy5093
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 662 | ||||||
| 322779267 | 403 | hypothetical protein SINV_02870 [Solenop | 0.542 | 0.890 | 0.703 | 1e-137 | |
| 383858579 | 457 | PREDICTED: dopamine receptor 2-like [Meg | 0.543 | 0.787 | 0.712 | 1e-137 | |
| 332023049 | 402 | Dopamine receptor 2 [Acromyrmex echinati | 0.561 | 0.925 | 0.684 | 1e-137 | |
| 307206398 | 404 | Dopamine receptor 2 [Harpegnathos saltat | 0.543 | 0.891 | 0.699 | 1e-136 | |
| 56044552 | 475 | dopamine receptor [Papilio xuthus] | 0.557 | 0.776 | 0.678 | 1e-135 | |
| 307181883 | 404 | Dopamine receptor 2 [Camponotus floridan | 0.558 | 0.915 | 0.673 | 1e-135 | |
| 340725553 | 457 | PREDICTED: dopamine receptor 2-like [Bom | 0.543 | 0.787 | 0.701 | 1e-134 | |
| 350415259 | 469 | PREDICTED: dopamine receptor 2-like [Bom | 0.543 | 0.767 | 0.698 | 1e-134 | |
| 380024653 | 460 | PREDICTED: dopamine receptor 2-like [Api | 0.528 | 0.760 | 0.713 | 1e-134 | |
| 58585084 | 456 | dopamine receptor 2 [Apis mellifera] gi| | 0.530 | 0.769 | 0.707 | 1e-134 |
| >gi|322779267|gb|EFZ09569.1| hypothetical protein SINV_02870 [Solenopsis invicta] | Back alignment and taxonomy information |
|---|
Score = 496 bits (1277), Expect = e-137, Method: Compositional matrix adjust.
Identities = 263/374 (70%), Positives = 304/374 (81%), Gaps = 15/374 (4%)
Query: 38 NFTLERWLELAQQRTLLVSTLSLFSLVTVFGNALVMIAVVRERYLHTSTNYFIMSLALAD 97
N T + ELA R L L LF + TVFGN+LV++AV RER+LHT+TNYF+ SLA AD
Sbjct: 35 NHTYDDLWELATDRIGLAIVLLLFCVATVFGNSLVILAVFRERHLHTATNYFVTSLACAD 94
Query: 98 CLVGLVVMPFSALYELLDHNWIFGLNWCDSWRSLDVLFSTASILNLCVISLDRYWAITDP 157
CLVGLVVMP SA+YE+L++ W+F +WCD WRSLDVLFSTASILNLCVISLDRYWAITDP
Sbjct: 95 CLVGLVVMPISAVYEVLENRWLFTTDWCDVWRSLDVLFSTASILNLCVISLDRYWAITDP 154
Query: 158 LTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSS 217
TYP+RMS +RA I IAIVWICS ISFPAI WWRAVR E+VPK+KCPFT++ GYLIFSS
Sbjct: 155 FTYPTRMSRKRAAILIAIVWICSSAISFPAIAWWRAVRTEQVPKDKCPFTENLGYLIFSS 214
Query: 218 TISFYLPLLVMVFTYFKIYRAAVVQTKSLKVGTKQVMSGSTSGEKELTLRIHRGG----- 272
TISFYLPL VMVFTY++IYRAAV+QT+SLK+GTKQVM SGE ELTLRIHRGG
Sbjct: 215 TISFYLPLFVMVFTYYRIYRAAVIQTRSLKLGTKQVMMA--SGELELTLRIHRGGVSTTN 272
Query: 273 TDHRHM--TLHHTPSDDVEMDNVMSG--HNGITRQVSNTRIIHKGHIVKNFSLSRKLSKF 328
TD RH+ T TP D +++ ++ +NG+TR V +TRI +K H+ KNFSLSRKL+KF
Sbjct: 273 TDARHLFRTASSTPEDLQDLEEPLTAFHNNGLTR-VPSTRINNKQHLGKNFSLSRKLAKF 331
Query: 329 AKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSG 388
AKEKKAAKTLGIVMGVFI+CWLPFFVVNLLS CT+C W EE++SA VTWLGWINSG
Sbjct: 332 AKEKKAAKTLGIVMGVFIICWLPFFVVNLLSGFCTRCIW---QEEMVSAAVTWLGWINSG 388
Query: 389 MNPVIYACWSRDFR 402
MNPVIYACWSRDFR
Sbjct: 389 MNPVIYACWSRDFR 402
|
Source: Solenopsis invicta Species: Solenopsis invicta Genus: Solenopsis Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383858579|ref|XP_003704778.1| PREDICTED: dopamine receptor 2-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
| >gi|332023049|gb|EGI63314.1| Dopamine receptor 2 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
| >gi|307206398|gb|EFN84440.1| Dopamine receptor 2 [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
| >gi|56044552|dbj|BAD72870.1| dopamine receptor [Papilio xuthus] | Back alignment and taxonomy information |
|---|
| >gi|307181883|gb|EFN69323.1| Dopamine receptor 2 [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
| >gi|340725553|ref|XP_003401133.1| PREDICTED: dopamine receptor 2-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
| >gi|350415259|ref|XP_003490584.1| PREDICTED: dopamine receptor 2-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
| >gi|380024653|ref|XP_003696107.1| PREDICTED: dopamine receptor 2-like [Apis florea] | Back alignment and taxonomy information |
|---|
| >gi|58585084|ref|NP_001011567.1| dopamine receptor 2 [Apis mellifera] gi|20336615|gb|AAM19330.1|AF498306_1 dopamine receptor type D2 [Apis mellifera] | Back alignment and taxonomy information |
|---|
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 662 | ||||||
| FB|FBgn0015129 | 539 | DopR2 "Dopamine receptor 2" [D | 0.348 | 0.428 | 0.683 | 1.3e-122 | |
| WB|WBGene00016872 | 517 | dop-4 [Caenorhabditis elegans | 0.299 | 0.382 | 0.467 | 7.7e-68 | |
| UNIPROTKB|Q18775 | 517 | dop-4 "Dopamine receptor 4" [C | 0.299 | 0.382 | 0.467 | 7.7e-68 | |
| UNIPROTKB|F1NIZ5 | 376 | ADRA1B "Uncharacterized protei | 0.291 | 0.513 | 0.441 | 8.6e-62 | |
| ZFIN|ZDB-GENE-041114-51 | 481 | adra1bb "adrenergic receptor, | 0.303 | 0.417 | 0.432 | 1.3e-61 | |
| UNIPROTKB|F1S8D0 | 571 | ADRA1D "Alpha-1D adrenergic re | 0.312 | 0.362 | 0.436 | 1.5e-60 | |
| UNIPROTKB|Q9TTM9 | 571 | ADRA1D "Alpha-1D adrenergic re | 0.312 | 0.362 | 0.436 | 1.5e-60 | |
| ZFIN|ZDB-GENE-090312-203 | 491 | adra1d "adrenergic receptor, a | 0.338 | 0.456 | 0.398 | 6.4e-60 | |
| UNIPROTKB|F1NK17 | 436 | F1NK17 "Uncharacterized protei | 0.291 | 0.442 | 0.431 | 1.1e-59 | |
| UNIPROTKB|F1MGA6 | 515 | ADRA1B "Uncharacterized protei | 0.291 | 0.374 | 0.441 | 1.2e-59 |
| FB|FBgn0015129 DopR2 "Dopamine receptor 2" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 833 (298.3 bits), Expect = 1.3e-122, Sum P(2) = 1.3e-122
Identities = 160/234 (68%), Positives = 185/234 (79%)
Query: 41 LERWLE-LAQQRXXXXXXXXXXXXXXXXGNALVMIAVVRERYLHTSTNYFIMSLALADCL 99
L +LE L R GN+LV++AV+RERYLHT+TNYFI SLA+ADCL
Sbjct: 97 LSEFLEALPNDRVGLLAFLFLFSFATVFGNSLVILAVIRERYLHTATNYFITSLAVADCL 156
Query: 100 VGLVVMPFSALYELLDHNWIFGLNWCDSWRSLDVLFSTASILNLCVISLDRYWAITDPLT 159
VGLVVMPFSALYE+L++ W FG +WCD WRSLDVLFSTASILNLCVISLDRYWAITDP +
Sbjct: 157 VGLVVMPFSALYEVLENTWFFGTDWCDIWRSLDVLFSTASILNLCVISLDRYWAITDPFS 216
Query: 160 YPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSSTI 219
YP RM+ +RA IA VWICS ISFPAI+WWRA R+ E+P KC FT+ GYL+FSSTI
Sbjct: 217 YPMRMTVKRAAGLIAAVWICSSAISFPAIVWWRAARDGEMPAYKCTFTEHLGYLVFSSTI 276
Query: 220 SFYLPLLVMVFTYFKIYRAAVVQTKSLKVGTKQVMSGSTSGEKELTLRIHRGGT 273
SFYLPLLVMVFTY +IYRAAV+QT+SLK+GTKQV+ S GE +LTLRIHRGGT
Sbjct: 277 SFYLPLLVMVFTYCRIYRAAVIQTRSLKIGTKQVLMAS--GELQLTLRIHRGGT 328
|
|
| WB|WBGene00016872 dop-4 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|Q18775 dop-4 "Dopamine receptor 4" [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1NIZ5 ADRA1B "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
| ZFIN|ZDB-GENE-041114-51 adra1bb "adrenergic receptor, alpha 1bb" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1S8D0 ADRA1D "Alpha-1D adrenergic receptor" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|Q9TTM9 ADRA1D "Alpha-1D adrenergic receptor" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
| ZFIN|ZDB-GENE-090312-203 adra1d "adrenergic receptor, alpha 1d" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1NK17 F1NK17 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1MGA6 ADRA1B "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Prediction of Enzyme Commission (EC) Number
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 662 | |||
| pfam00001 | 251 | pfam00001, 7tm_1, 7 transmembrane receptor (rhodop | 6e-45 | |
| pfam00001 | 251 | pfam00001, 7tm_1, 7 transmembrane receptor (rhodop | 2e-15 | |
| pfam00001 | 251 | pfam00001, 7tm_1, 7 transmembrane receptor (rhodop | 2e-15 | |
| PHA03087 | 335 | PHA03087, PHA03087, G protein-coupled chemokine re | 3e-12 | |
| pfam00001 | 251 | pfam00001, 7tm_1, 7 transmembrane receptor (rhodop | 2e-05 | |
| PHA02638 | 417 | PHA02638, PHA02638, CC chemokine receptor-like pro | 2e-05 | |
| PHA02834 | 323 | PHA02834, PHA02834, chemokine receptor-like protei | 0.001 |
| >gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 6e-45
Identities = 60/187 (32%), Positives = 91/187 (48%), Gaps = 6/187 (3%)
Query: 74 IAVVRERYLHTSTNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLNWCDSWRSLDV 133
+ ++R + L T TN F+++LA+AD L L + P++ Y + W FG C L V
Sbjct: 1 LVILRTKKLRTPTNIFLLNLAVADLLFLLTLPPWALYYLVGGD-WPFGDALCKLVGFLFV 59
Query: 134 LFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRA 193
+ ASIL L IS+DRY AI PL Y + RRA + I +VW+ + +S P +L+
Sbjct: 60 VNGYASILLLTAISIDRYLAIVHPLRYRRIRTPRRAKVLILVVWVLALLLSLPPLLFSWL 119
Query: 194 VRNEEVPKNKCPFTD-----SKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKV 248
EE C + Y + S+ + F LPLLV++ Y I R + +S
Sbjct: 120 RTVEEGNVTTCLIDFPEESTKRSYTLLSTLLGFVLPLLVILVCYTLILRTLRKRARSGAS 179
Query: 249 GTKQVMS 255
+ S
Sbjct: 180 QARAKRS 186
|
This family contains, amongst other G-protein-coupled receptors (GCPRs), members of the opsin family, which have been considered to be typical members of the rhodopsin superfamily. They share several motifs, mainly the seven transmembrane helices, GCPRs of the rhodopsin superfamily. All opsins bind a chromophore, such as 11-cis-retinal. The function of most opsins other than the photoisomerases is split into two steps: light absorption and G-protein activation. Photoisomerases, on the other hand, are not coupled to G-proteins - they are thought to generate and supply the chromophore that is used by visual opsins. Length = 251 |
| >gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) | Back alignment and domain information |
|---|
| >gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) | Back alignment and domain information |
|---|
| >gnl|CDD|222976 PHA03087, PHA03087, G protein-coupled chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) | Back alignment and domain information |
|---|
| >gnl|CDD|165021 PHA02638, PHA02638, CC chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >gnl|CDD|165177 PHA02834, PHA02834, chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 662 | |||
| KOG4219|consensus | 423 | 100.0 | ||
| KOG4220|consensus | 503 | 100.0 | ||
| PHA03234 | 338 | DNA packaging protein UL33; Provisional | 100.0 | |
| PHA03235 | 409 | DNA packaging protein UL33; Provisional | 100.0 | |
| PHA02834 | 323 | chemokine receptor-like protein; Provisional | 100.0 | |
| PHA02638 | 417 | CC chemokine receptor-like protein; Provisional | 100.0 | |
| PHA03087 | 335 | G protein-coupled chemokine receptor-like protein; | 100.0 | |
| PF00001 | 257 | 7tm_1: 7 transmembrane receptor (rhodopsin family) | 99.97 | |
| KOG4220|consensus | 503 | 99.94 | ||
| KOG2087|consensus | 363 | 99.9 | ||
| PF10320 | 257 | 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemorecep | 99.86 | |
| KOG4219|consensus | 423 | 99.84 | ||
| PHA03234 | 338 | DNA packaging protein UL33; Provisional | 99.84 | |
| PHA03235 | 409 | DNA packaging protein UL33; Provisional | 99.83 | |
| PF10324 | 318 | 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemorecept | 99.83 | |
| PHA02834 | 323 | chemokine receptor-like protein; Provisional | 99.79 | |
| PHA02638 | 417 | CC chemokine receptor-like protein; Provisional | 99.77 | |
| PF10328 | 274 | 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemorecept | 99.73 | |
| PHA03087 | 335 | G protein-coupled chemokine receptor-like protein; | 99.71 | |
| PF00001 | 257 | 7tm_1: 7 transmembrane receptor (rhodopsin family) | 99.68 | |
| PF05296 | 303 | TAS2R: Mammalian taste receptor protein (TAS2R); I | 99.65 | |
| PF10323 | 283 | 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemorecept | 99.58 | |
| PF05462 | 303 | Dicty_CAR: Slime mold cyclic AMP receptor | 99.56 | |
| PF10321 | 313 | 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemorecept | 99.51 | |
| PF03402 | 265 | V1R: Vomeronasal organ pheromone receptor family, | 99.12 | |
| PF10317 | 292 | 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemorecept | 99.11 | |
| KOG2087|consensus | 363 | 98.9 | ||
| PF11710 | 201 | Git3: G protein-coupled glucose receptor regulatin | 98.83 | |
| KOG4193|consensus | 610 | 98.68 | ||
| PF10327 | 303 | 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemorecept | 98.6 | |
| PF10292 | 324 | 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor c | 98.6 | |
| PF02118 | 275 | Srg: Srg family chemoreceptor; InterPro: IPR000609 | 98.55 | |
| PF02101 | 405 | Ocular_alb: Ocular albinism type 1 protein; InterP | 98.53 | |
| PF10324 | 318 | 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemorecept | 98.46 | |
| PF10326 | 307 | 7TM_GPCR_Str: Serpentine type 7TM GPCR chemorecept | 98.33 | |
| PF04789 | 305 | DUF621: Protein of unknown function (DUF621); Inte | 98.23 | |
| KOG4564|consensus | 473 | 98.22 | ||
| PF10318 | 302 | 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemorecept | 98.21 | |
| PF10319 | 310 | 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemorecept | 98.18 | |
| PF10316 | 273 | 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemorecep | 98.17 | |
| PF05296 | 303 | TAS2R: Mammalian taste receptor protein (TAS2R); I | 98.01 | |
| PF00002 | 242 | 7tm_2: 7 transmembrane receptor (Secretin family); | 97.99 | |
| PF03125 | 365 | Sre: C. elegans Sre G protein-coupled chemorecepto | 97.66 | |
| PF10321 | 313 | 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemorecept | 97.6 | |
| PF02117 | 328 | 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemorecept | 97.56 | |
| PF10323 | 283 | 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemorecept | 97.46 | |
| PF10322 | 307 | 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemorecept | 97.39 | |
| PF10320 | 257 | 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemorecep | 97.22 | |
| PF02076 | 283 | STE3: Pheromone A receptor; InterPro: IPR001499 G- | 97.16 | |
| PF05462 | 303 | Dicty_CAR: Slime mold cyclic AMP receptor | 97.04 | |
| PF01534 | 328 | Frizzled: Frizzled/Smoothened family membrane regi | 96.7 | |
| PF10328 | 274 | 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemorecept | 96.16 | |
| PF06681 | 226 | DUF1182: Protein of unknown function (DUF1182); In | 96.06 | |
| PF11970 | 76 | Git3_C: G protein-coupled glucose receptor regulat | 95.81 | |
| PF10327 | 303 | 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemorecept | 95.58 | |
| PF11970 | 76 | Git3_C: G protein-coupled glucose receptor regulat | 95.03 | |
| PF03402 | 265 | V1R: Vomeronasal organ pheromone receptor family, | 94.3 | |
| PF02101 | 405 | Ocular_alb: Ocular albinism type 1 protein; InterP | 94.16 | |
| PF02175 | 236 | 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemorecept | 94.03 | |
| PF04789 | 305 | DUF621: Protein of unknown function (DUF621); Inte | 92.83 | |
| PF03383 | 153 | Serpentine_r_xa: Caenorhabditis serpentine recepto | 92.29 | |
| PF13853 | 144 | 7tm_4: Olfactory receptor | 89.41 | |
| PF10317 | 292 | 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemorecept | 88.28 |
| >KOG4219|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=326.80 Aligned_cols=293 Identities=26% Similarity=0.446 Sum_probs=245.8
Q ss_pred hHhHHhHHHHHHHHHHHHHHHHHHhhHhhhhheeccccccchhhHHHHHHHHHHHhhhhhcccHHHHHhhcccccccccc
Q psy5093 44 WLELAQQRTLLVSTLSLFSLVTVFGNALVMIAVVRERYLHTSTNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLN 123 (662)
Q Consensus 44 ~~~~~~~~~i~~~~~~ii~i~gl~gN~~vi~~i~~~~~lr~~~~~ll~~Lai~Dll~~l~~~p~~~~~~~~~~~~~~~~~ 123 (662)
+....+.+.+.+++++++.+++++||.+|++++..+|++|+.+|+|++|||+||++.+++..++.....+ ..+|.+|.+
T Consensus 28 f~lp~~~~~~wai~yg~l~~vAv~GN~iVlwIil~hrrMRtvtnyfL~NLAfADl~~s~Fn~~f~f~yal-~~~W~~G~f 106 (423)
T KOG4219|consen 28 FVLPAWQQALWAIAYGLLVFVAVVGNLIVLWIILAHRRMRTVTNYFLVNLAFADLSMSIFNTVFNFQYAL-HQEWYFGSF 106 (423)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhcCceEEEEEeehhehhhhHHHHHHHHHHHHHHHHHHhhHHHHHHHH-Hhccccccc
Confidence 4456667899999999999999999999999999999999999999999999999999999998777665 468999999
Q ss_pred chhHHHHhhHHHHHHHHHHHHHHHHHHhhhhcCCCCCCccccchhhhHHHHHHHHHHHhhhhhHHHhhhccccCCC---C
Q psy5093 124 WCDSWRSLDVLFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEV---P 200 (662)
Q Consensus 124 ~C~~~~~~~~~~~~~s~~~l~~iaidRy~~I~~P~~y~~~~t~~~~~~~i~~~w~~s~~~~~~~~~~~~~~~~~~~---~ 200 (662)
+|++..|+..+...+|++++++||+|||.||.+|++. +.+++...++++++|++++++++|..+.......... .
T Consensus 107 ~C~f~nf~~itav~vSVfTlvAiA~DRy~AIi~Pl~~--r~s~r~sk~iIllIW~lA~l~a~P~~l~s~v~~~~~~d~~~ 184 (423)
T KOG4219|consen 107 YCRFVNFFPITAVFVSVFTLVAIAIDRYMAIIHPLQP--RPSRRSSKIIILLIWALALLLALPQLLYSSVEELYLYDGES 184 (423)
T ss_pred eeeeccccchhhhhHhHHHHHHHHHHHHHHHhhhccc--CCCCcceeehhHHHHHHHHHHhccceeeeeeEEeeccCCcc
Confidence 9999999999999999999999999999999999984 3899999999999999999999999987655533221 1
Q ss_pred CCcc---------ccCC----CcchhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccCCcccccCCCCCCccceee
Q psy5093 201 KNKC---------PFTD----SKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKVGTKQVMSGSTSGEKELTLR 267 (662)
Q Consensus 201 ~~~c---------~~~~----~~~~~~~~~~~~~~ip~~ii~~~y~~I~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (662)
...| .... ...|.....++.+++|++++.++|..|.+++|..+.....
T Consensus 185 ~~~~~~~~pe~~~~~~~~~~~~~~y~~vl~~lqYflPliVl~~~Yt~iav~LW~~~~~gd~------------------- 245 (423)
T KOG4219|consen 185 RVVCVTAWPEHVCPTENESLLMQGYNYVLLFLQYFLPLIVLGLAYTVIAVTLWGRRIPGDQ------------------- 245 (423)
T ss_pred eEEEEEecccccCCcchhhhhhcceeeeehhHHHHHHHHHHHHHHHHHHHHHHhccCccch-------------------
Confidence 1222 2111 2337888899999999999999999999999975421100
Q ss_pred eccCCCCCCCCccCCCCCCccccccccccCCCccccccccccccccccccccccccchhhHHhhhhhHHHHHHHHHHHHh
Q psy5093 268 IHRGGTDHRHMTLHHTPSDDVEMDNVMSGHNGITRQVSNTRIIHKGHIVKNFSLSRKLSKFAKEKKAAKTLGIVMGVFIV 347 (662)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~f~i 347 (662)
..+..+..+..+|+.||++++++.|.+
T Consensus 246 -----------------------------------------------------~d~~~~~~kak~K~vkmliiVV~~Fai 272 (423)
T KOG4219|consen 246 -----------------------------------------------------QDRKHEQLKAKKKVVKMLIIVVVIFAI 272 (423)
T ss_pred -----------------------------------------------------hchhhHHHHHHHHHHHHHHHHHHHHHH
Confidence 002223445788999999999999999
Q ss_pred hhhhHHHHHHHHHhhccccCCCchhHHHHHHHHHHHHhhccccchhhhhcChhHHHHHHHhcccC
Q psy5093 348 CWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFRSKEKILNHKI 412 (662)
Q Consensus 348 ~~~P~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ns~~nP~IY~~~~~~fR~~~~~l~~~~ 412 (662)
||+|+.+..++....++.. ........+....||+..|+++||+||++.|++||.++++.||.|
T Consensus 273 cWlPyh~y~il~~~~~~i~-~~k~i~~vyl~~~WLaMSst~yNPiIY~~lN~Rfr~gf~~~fr~c 336 (423)
T KOG4219|consen 273 CWLPYHIYFILNATNPEIN-RKKFIQQVYLAIYWLAMSSTCYNPIIYCFLNKRFRGGFRRAFRWC 336 (423)
T ss_pred hccChhHHHHHHHhHHHHH-HHHHHHHHHHHHHHHHHHHhhhccHhhhhhHHHHHHHHhhhhhee
Confidence 9999999999987654422 344556678899999999999999999999999999999999775
|
|
| >KOG4220|consensus | Back alignment and domain information |
|---|
| >PHA03234 DNA packaging protein UL33; Provisional | Back alignment and domain information |
|---|
| >PHA03235 DNA packaging protein UL33; Provisional | Back alignment and domain information |
|---|
| >PHA02834 chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PHA02638 CC chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PHA03087 G protein-coupled chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PF00001 7tm_1: 7 transmembrane receptor (rhodopsin family) Rhodopsin-like GPCR superfamily signature 5-hydroxytryptamine 7 receptor signature bradykinin receptor signature gastrin receptor signature melatonin receptor signature olfactory receptor signature; InterPro: IPR000276 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >KOG4220|consensus | Back alignment and domain information |
|---|
| >KOG2087|consensus | Back alignment and domain information |
|---|
| >PF10320 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemoreceptor Srsx; InterPro: IPR019424 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >KOG4219|consensus | Back alignment and domain information |
|---|
| >PHA03234 DNA packaging protein UL33; Provisional | Back alignment and domain information |
|---|
| >PHA03235 DNA packaging protein UL33; Provisional | Back alignment and domain information |
|---|
| >PF10324 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemoreceptor Srw; InterPro: IPR019427 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PHA02834 chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PHA02638 CC chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PF10328 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemoreceptor Srx; InterPro: IPR019430 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PHA03087 G protein-coupled chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PF00001 7tm_1: 7 transmembrane receptor (rhodopsin family) Rhodopsin-like GPCR superfamily signature 5-hydroxytryptamine 7 receptor signature bradykinin receptor signature gastrin receptor signature melatonin receptor signature olfactory receptor signature; InterPro: IPR000276 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF05296 TAS2R: Mammalian taste receptor protein (TAS2R); InterPro: IPR007960 This family consists of several forms of mammalian taste receptor proteins (TAS2Rs) | Back alignment and domain information |
|---|
| >PF10323 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemoreceptor Srv; InterPro: IPR019426 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF05462 Dicty_CAR: Slime mold cyclic AMP receptor | Back alignment and domain information |
|---|
| >PF10321 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemoreceptor Srt; InterPro: IPR019425 Chemoreception is mediated in Caenorhabditis elegans by members of the seven-transmembrane G-protein-coupled receptor class (7TM GPCRs) of proteins which are of the serpentine type [] | Back alignment and domain information |
|---|
| >PF03402 V1R: Vomeronasal organ pheromone receptor family, V1R; InterPro: IPR004072 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10317 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemoreceptor Srd; InterPro: IPR019421 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >KOG2087|consensus | Back alignment and domain information |
|---|
| >PF11710 Git3: G protein-coupled glucose receptor regulating Gpa2; InterPro: IPR023041 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor | Back alignment and domain information |
|---|
| >KOG4193|consensus | Back alignment and domain information |
|---|
| >PF10327 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemoreceptor Sri; InterPro: IPR019429 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10292 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor class ab chemoreceptor; InterPro: IPR019408 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF02118 Srg: Srg family chemoreceptor; InterPro: IPR000609 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF02101 Ocular_alb: Ocular albinism type 1 protein; InterPro: IPR001414 Ocular albinism type 1 (OA1) is an X-linked disorder characterised by severe impairment of visual acuity, retinal hypopigmentation and the presence of macromelanosomes | Back alignment and domain information |
|---|
| >PF10324 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemoreceptor Srw; InterPro: IPR019427 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10326 7TM_GPCR_Str: Serpentine type 7TM GPCR chemoreceptor Str; InterPro: IPR019428 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF04789 DUF621: Protein of unknown function (DUF621); InterPro: IPR006874 This is a conserved region found in uncharacterised proteins from Caenorhabditis elegans, and is noted to have possible G-protein-coupled receptor-like activity | Back alignment and domain information |
|---|
| >KOG4564|consensus | Back alignment and domain information |
|---|
| >PF10318 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemoreceptor Srh; InterPro: IPR019422 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10319 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemoreceptor Srj; InterPro: IPR019423 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10316 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemoreceptor Srbc ; InterPro: IPR019420 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF05296 TAS2R: Mammalian taste receptor protein (TAS2R); InterPro: IPR007960 This family consists of several forms of mammalian taste receptor proteins (TAS2Rs) | Back alignment and domain information |
|---|
| >PF00002 7tm_2: 7 transmembrane receptor (Secretin family); InterPro: IPR000832 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF03125 Sre: C | Back alignment and domain information |
|---|
| >PF10321 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemoreceptor Srt; InterPro: IPR019425 Chemoreception is mediated in Caenorhabditis elegans by members of the seven-transmembrane G-protein-coupled receptor class (7TM GPCRs) of proteins which are of the serpentine type [] | Back alignment and domain information |
|---|
| >PF02117 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemoreceptor Sra; InterPro: IPR000344 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10323 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemoreceptor Srv; InterPro: IPR019426 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10322 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemoreceptor Sru; InterPro: IPR003839 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10320 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemoreceptor Srsx; InterPro: IPR019424 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF02076 STE3: Pheromone A receptor; InterPro: IPR001499 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF05462 Dicty_CAR: Slime mold cyclic AMP receptor | Back alignment and domain information |
|---|
| >PF01534 Frizzled: Frizzled/Smoothened family membrane region; InterPro: IPR000539 The frizzled (fz) locus of Drosophila coordinates the cytoskeletons of epidermal cells, producing a parallel array of cuticular hairs and bristles [, ] | Back alignment and domain information |
|---|
| >PF10328 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemoreceptor Srx; InterPro: IPR019430 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF06681 DUF1182: Protein of unknown function (DUF1182); InterPro: IPR010601 This family consists of several hypothetical proteins of around 360 residues in length and seems to be specific to Caenorhabditis elegans | Back alignment and domain information |
|---|
| >PF11970 Git3_C: G protein-coupled glucose receptor regulating Gpa2 C-term; InterPro: IPR022596 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor | Back alignment and domain information |
|---|
| >PF10327 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemoreceptor Sri; InterPro: IPR019429 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF11970 Git3_C: G protein-coupled glucose receptor regulating Gpa2 C-term; InterPro: IPR022596 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor | Back alignment and domain information |
|---|
| >PF03402 V1R: Vomeronasal organ pheromone receptor family, V1R; InterPro: IPR004072 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF02101 Ocular_alb: Ocular albinism type 1 protein; InterPro: IPR001414 Ocular albinism type 1 (OA1) is an X-linked disorder characterised by severe impairment of visual acuity, retinal hypopigmentation and the presence of macromelanosomes | Back alignment and domain information |
|---|
| >PF02175 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemoreceptor Srb; InterPro: IPR002184 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF04789 DUF621: Protein of unknown function (DUF621); InterPro: IPR006874 This is a conserved region found in uncharacterised proteins from Caenorhabditis elegans, and is noted to have possible G-protein-coupled receptor-like activity | Back alignment and domain information |
|---|
| >PF03383 Serpentine_r_xa: Caenorhabditis serpentine receptor-like protein, class xa; InterPro: IPR005047 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF13853 7tm_4: Olfactory receptor | Back alignment and domain information |
|---|
| >PF10317 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemoreceptor Srd; InterPro: IPR019421 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 662 | ||||
| 3sn6_R | 514 | Crystal Structure Of The Beta2 Adrenergic Receptor- | 4e-53 | ||
| 3sn6_R | 514 | Crystal Structure Of The Beta2 Adrenergic Receptor- | 2e-21 | ||
| 3kj6_A | 366 | Crystal Structure Of A Methylated Beta2 Adrenergic | 2e-52 | ||
| 3kj6_A | 366 | Crystal Structure Of A Methylated Beta2 Adrenergic | 5e-21 | ||
| 2r4s_A | 342 | Crystal Structure Of The Human Beta2 Adrenoceptor L | 3e-52 | ||
| 2r4s_A | 342 | Crystal Structure Of The Human Beta2 Adrenoceptor L | 8e-21 | ||
| 2r4r_A | 365 | Crystal Structure Of The Human Beta2 Adrenoceptor L | 3e-52 | ||
| 2r4r_A | 365 | Crystal Structure Of The Human Beta2 Adrenoceptor L | 7e-21 | ||
| 4gbr_A | 309 | N-terminal T4 Lysozyme Fusion Facilitates Crystalli | 1e-36 | ||
| 4gbr_A | 309 | N-terminal T4 Lysozyme Fusion Facilitates Crystalli | 9e-14 | ||
| 4gbr_A | 309 | N-terminal T4 Lysozyme Fusion Facilitates Crystalli | 9e-14 | ||
| 3p0g_A | 501 | Structure Of A Nanobody-Stabilized Active State Of | 2e-36 | ||
| 3p0g_A | 501 | Structure Of A Nanobody-Stabilized Active State Of | 2e-13 | ||
| 3p0g_A | 501 | Structure Of A Nanobody-Stabilized Active State Of | 2e-13 | ||
| 2rh1_A | 500 | High Resolution Crystal Structure Of Human B2-Adren | 2e-36 | ||
| 2rh1_A | 500 | High Resolution Crystal Structure Of Human B2-Adren | 2e-13 | ||
| 2rh1_A | 500 | High Resolution Crystal Structure Of Human B2-Adren | 2e-13 | ||
| 3d4s_A | 490 | Cholesterol Bound Form Of Human Beta2 Adrenergic Re | 4e-36 | ||
| 3d4s_A | 490 | Cholesterol Bound Form Of Human Beta2 Adrenergic Re | 2e-13 | ||
| 3d4s_A | 490 | Cholesterol Bound Form Of Human Beta2 Adrenergic Re | 2e-13 | ||
| 3pds_A | 458 | Irreversible Agonist-Beta2 Adrenoceptor Complex Len | 7e-36 | ||
| 3pds_A | 458 | Irreversible Agonist-Beta2 Adrenoceptor Complex Len | 3e-13 | ||
| 3pds_A | 458 | Irreversible Agonist-Beta2 Adrenoceptor Complex Len | 3e-13 | ||
| 2vt4_A | 313 | Turkey Beta1 Adrenergic Receptor With Stabilising M | 7e-34 | ||
| 2vt4_A | 313 | Turkey Beta1 Adrenergic Receptor With Stabilising M | 3e-13 | ||
| 2vt4_A | 313 | Turkey Beta1 Adrenergic Receptor With Stabilising M | 3e-13 | ||
| 2y00_B | 315 | Turkey Beta1 Adrenergic Receptor With Stabilising M | 7e-34 | ||
| 2y00_B | 315 | Turkey Beta1 Adrenergic Receptor With Stabilising M | 6e-13 | ||
| 3uon_A | 467 | Structure Of The Human M2 Muscarinic Acetylcholine | 9e-28 | ||
| 3uon_A | 467 | Structure Of The Human M2 Muscarinic Acetylcholine | 1e-04 | ||
| 3pbl_A | 481 | Structure Of The Human Dopamine D3 Receptor In Comp | 2e-27 | ||
| 3pbl_A | 481 | Structure Of The Human Dopamine D3 Receptor In Comp | 2e-14 | ||
| 4daj_A | 479 | Structure Of The M3 Muscarinic Acetylcholine Recept | 3e-27 | ||
| 4daj_A | 479 | Structure Of The M3 Muscarinic Acetylcholine Recept | 3e-07 | ||
| 4daj_A | 479 | Structure Of The M3 Muscarinic Acetylcholine Recept | 1e-06 | ||
| 4eiy_A | 447 | Crystal Structure Of The Chimeric Protein Of A2aar- | 1e-26 | ||
| 4eiy_A | 447 | Crystal Structure Of The Chimeric Protein Of A2aar- | 4e-11 | ||
| 3rze_A | 452 | Structure Of The Human Histamine H1 Receptor In Com | 1e-22 | ||
| 3rze_A | 452 | Structure Of The Human Histamine H1 Receptor In Com | 7e-12 | ||
| 3rze_A | 452 | Structure Of The Human Histamine H1 Receptor In Com | 1e-11 | ||
| 2ydo_A | 325 | Thermostabilised Human A2a Receptor With Adenosine | 9e-18 | ||
| 2ydo_A | 325 | Thermostabilised Human A2a Receptor With Adenosine | 3e-07 | ||
| 3vg9_A | 326 | Crystal Structure Of Human Adenosine A2a Receptor W | 1e-17 | ||
| 3vg9_A | 326 | Crystal Structure Of Human Adenosine A2a Receptor W | 3e-07 | ||
| 3pwh_A | 329 | Thermostabilised Adenosine A2a Receptor Length = 32 | 1e-17 | ||
| 3pwh_A | 329 | Thermostabilised Adenosine A2a Receptor Length = 32 | 2e-06 | ||
| 3eml_A | 488 | The 2.6 A Crystal Structure Of A Human A2a Adenosin | 1e-13 | ||
| 3eml_A | 488 | The 2.6 A Crystal Structure Of A Human A2a Adenosin | 7e-07 | ||
| 2ziy_A | 372 | Crystal Structure Of Squid Rhodopsin Length = 372 | 3e-13 | ||
| 2z73_A | 448 | Crystal Structure Of Squid Rhodopsin Length = 448 | 4e-13 | ||
| 4djh_A | 480 | Structure Of The Human Kappa Opioid Receptor In Com | 2e-12 | ||
| 4dkl_A | 464 | Crystal Structure Of The Mu-Opioid Receptor Bound T | 5e-11 | ||
| 4ea3_B | 434 | Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WI | 6e-11 | ||
| 4ej4_A | 461 | Structure Of The Delta Opioid Receptor Bound To Nal | 1e-10 | ||
| 2x72_A | 349 | Crystal Structure Of The Constitutively Active E113 | 1e-08 | ||
| 3oax_A | 349 | Crystal Structure Of Bovine Rhodopsin With Beta-Ion | 1e-08 | ||
| 1jfp_A | 348 | Structure Of Bovine Rhodopsin (Dark Adapted) Length | 1e-08 | ||
| 2j4y_A | 349 | Crystal Structure Of A Rhodopsin Stabilizing Mutant | 1e-08 | ||
| 3c9m_A | 348 | Structure Of A Mutant Bovine Rhodopsin In Hexagonal | 1e-08 | ||
| 4a4m_A | 349 | Crystal Structure Of The Light-Activated Constituti | 2e-08 | ||
| 2ks9_A | 364 | Solution Conformation Of Substance P In Water Compl | 3e-07 | ||
| 4grv_A | 510 | The Crystal Structure Of The Neurotensin Receptor N | 3e-05 | ||
| 3v2w_A | 520 | Crystal Structure Of A Lipid G Protein-Coupled Rece | 9e-05 |
| >pdb|3SN6|R Chain R, Crystal Structure Of The Beta2 Adrenergic Receptor-Gs Protein Complex Length = 514 | Back alignment and structure |
|
| >pdb|3SN6|R Chain R, Crystal Structure Of The Beta2 Adrenergic Receptor-Gs Protein Complex Length = 514 | Back alignment and structure |
| >pdb|3KJ6|A Chain A, Crystal Structure Of A Methylated Beta2 Adrenergic Receptor- Fab Complex Length = 366 | Back alignment and structure |
| >pdb|3KJ6|A Chain A, Crystal Structure Of A Methylated Beta2 Adrenergic Receptor- Fab Complex Length = 366 | Back alignment and structure |
| >pdb|2R4S|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 342 | Back alignment and structure |
| >pdb|2R4S|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 342 | Back alignment and structure |
| >pdb|2R4R|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 365 | Back alignment and structure |
| >pdb|2R4R|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 365 | Back alignment and structure |
| >pdb|4GBR|A Chain A, N-terminal T4 Lysozyme Fusion Facilitates Crystallization Of A G Protein Coupled Receptor Length = 309 | Back alignment and structure |
| >pdb|4GBR|A Chain A, N-terminal T4 Lysozyme Fusion Facilitates Crystallization Of A G Protein Coupled Receptor Length = 309 | Back alignment and structure |
| >pdb|4GBR|A Chain A, N-terminal T4 Lysozyme Fusion Facilitates Crystallization Of A G Protein Coupled Receptor Length = 309 | Back alignment and structure |
| >pdb|3P0G|A Chain A, Structure Of A Nanobody-Stabilized Active State Of The Beta2 Adrenoceptor Length = 501 | Back alignment and structure |
| >pdb|3P0G|A Chain A, Structure Of A Nanobody-Stabilized Active State Of The Beta2 Adrenoceptor Length = 501 | Back alignment and structure |
| >pdb|3P0G|A Chain A, Structure Of A Nanobody-Stabilized Active State Of The Beta2 Adrenoceptor Length = 501 | Back alignment and structure |
| >pdb|2RH1|A Chain A, High Resolution Crystal Structure Of Human B2-Adrenergic G Protein- Coupled Receptor Length = 500 | Back alignment and structure |
| >pdb|2RH1|A Chain A, High Resolution Crystal Structure Of Human B2-Adrenergic G Protein- Coupled Receptor Length = 500 | Back alignment and structure |
| >pdb|2RH1|A Chain A, High Resolution Crystal Structure Of Human B2-Adrenergic G Protein- Coupled Receptor Length = 500 | Back alignment and structure |
| >pdb|3D4S|A Chain A, Cholesterol Bound Form Of Human Beta2 Adrenergic Receptor. Length = 490 | Back alignment and structure |
| >pdb|3D4S|A Chain A, Cholesterol Bound Form Of Human Beta2 Adrenergic Receptor. Length = 490 | Back alignment and structure |
| >pdb|3D4S|A Chain A, Cholesterol Bound Form Of Human Beta2 Adrenergic Receptor. Length = 490 | Back alignment and structure |
| >pdb|3PDS|A Chain A, Irreversible Agonist-Beta2 Adrenoceptor Complex Length = 458 | Back alignment and structure |
| >pdb|3PDS|A Chain A, Irreversible Agonist-Beta2 Adrenoceptor Complex Length = 458 | Back alignment and structure |
| >pdb|3PDS|A Chain A, Irreversible Agonist-Beta2 Adrenoceptor Complex Length = 458 | Back alignment and structure |
| >pdb|2VT4|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Cyanopindolol Length = 313 | Back alignment and structure |
| >pdb|2VT4|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Cyanopindolol Length = 313 | Back alignment and structure |
| >pdb|2VT4|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Cyanopindolol Length = 313 | Back alignment and structure |
| >pdb|2Y00|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Partial Agonist Dobutamine (Crystal Dob92) Length = 315 | Back alignment and structure |
| >pdb|2Y00|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Partial Agonist Dobutamine (Crystal Dob92) Length = 315 | Back alignment and structure |
| >pdb|3UON|A Chain A, Structure Of The Human M2 Muscarinic Acetylcholine Receptor Bound To An Antagonist Length = 467 | Back alignment and structure |
| >pdb|3UON|A Chain A, Structure Of The Human M2 Muscarinic Acetylcholine Receptor Bound To An Antagonist Length = 467 | Back alignment and structure |
| >pdb|3PBL|A Chain A, Structure Of The Human Dopamine D3 Receptor In Complex With Eticlopride Length = 481 | Back alignment and structure |
| >pdb|3PBL|A Chain A, Structure Of The Human Dopamine D3 Receptor In Complex With Eticlopride Length = 481 | Back alignment and structure |
| >pdb|4DAJ|A Chain A, Structure Of The M3 Muscarinic Acetylcholine Receptor Length = 479 | Back alignment and structure |
| >pdb|4DAJ|A Chain A, Structure Of The M3 Muscarinic Acetylcholine Receptor Length = 479 | Back alignment and structure |
| >pdb|4DAJ|A Chain A, Structure Of The M3 Muscarinic Acetylcholine Receptor Length = 479 | Back alignment and structure |
| >pdb|4EIY|A Chain A, Crystal Structure Of The Chimeric Protein Of A2aar-Bril In Complex With Zm241385 At 1.8a Resolution Length = 447 | Back alignment and structure |
| >pdb|4EIY|A Chain A, Crystal Structure Of The Chimeric Protein Of A2aar-Bril In Complex With Zm241385 At 1.8a Resolution Length = 447 | Back alignment and structure |
| >pdb|3RZE|A Chain A, Structure Of The Human Histamine H1 Receptor In Complex With Doxepin Length = 452 | Back alignment and structure |
| >pdb|3RZE|A Chain A, Structure Of The Human Histamine H1 Receptor In Complex With Doxepin Length = 452 | Back alignment and structure |
| >pdb|3RZE|A Chain A, Structure Of The Human Histamine H1 Receptor In Complex With Doxepin Length = 452 | Back alignment and structure |
| >pdb|2YDO|A Chain A, Thermostabilised Human A2a Receptor With Adenosine Bound Length = 325 | Back alignment and structure |
| >pdb|2YDO|A Chain A, Thermostabilised Human A2a Receptor With Adenosine Bound Length = 325 | Back alignment and structure |
| >pdb|3VG9|A Chain A, Crystal Structure Of Human Adenosine A2a Receptor With An Allosteric Inverse-Agonist Antibody At 2.7 A Resolution Length = 326 | Back alignment and structure |
| >pdb|3VG9|A Chain A, Crystal Structure Of Human Adenosine A2a Receptor With An Allosteric Inverse-Agonist Antibody At 2.7 A Resolution Length = 326 | Back alignment and structure |
| >pdb|3PWH|A Chain A, Thermostabilised Adenosine A2a Receptor Length = 329 | Back alignment and structure |
| >pdb|3PWH|A Chain A, Thermostabilised Adenosine A2a Receptor Length = 329 | Back alignment and structure |
| >pdb|3EML|A Chain A, The 2.6 A Crystal Structure Of A Human A2a Adenosine Receptor Bound To Zm241385. Length = 488 | Back alignment and structure |
| >pdb|3EML|A Chain A, The 2.6 A Crystal Structure Of A Human A2a Adenosine Receptor Bound To Zm241385. Length = 488 | Back alignment and structure |
| >pdb|2ZIY|A Chain A, Crystal Structure Of Squid Rhodopsin Length = 372 | Back alignment and structure |
| >pdb|2Z73|A Chain A, Crystal Structure Of Squid Rhodopsin Length = 448 | Back alignment and structure |
| >pdb|4DJH|A Chain A, Structure Of The Human Kappa Opioid Receptor In Complex With Jdtic Length = 480 | Back alignment and structure |
| >pdb|4DKL|A Chain A, Crystal Structure Of The Mu-Opioid Receptor Bound To A Morphinan Antagonist Length = 464 | Back alignment and structure |
| >pdb|4EA3|B Chain B, Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WITH A PEPTIDE Mimetic Length = 434 | Back alignment and structure |
| >pdb|4EJ4|A Chain A, Structure Of The Delta Opioid Receptor Bound To Naltrindole Length = 461 | Back alignment and structure |
| >pdb|2X72|A Chain A, Crystal Structure Of The Constitutively Active E113q,N2c, D282c Rhodopsin Mutant With Bound Galphact Peptide Length = 349 | Back alignment and structure |
| >pdb|3OAX|A Chain A, Crystal Structure Of Bovine Rhodopsin With Beta-Ionone Length = 349 | Back alignment and structure |
| >pdb|1JFP|A Chain A, Structure Of Bovine Rhodopsin (Dark Adapted) Length = 348 | Back alignment and structure |
| >pdb|2J4Y|A Chain A, Crystal Structure Of A Rhodopsin Stabilizing Mutant Expressed In Mammalian Cells Length = 349 | Back alignment and structure |
| >pdb|3C9M|A Chain A, Structure Of A Mutant Bovine Rhodopsin In Hexagonal Crystal Form Length = 348 | Back alignment and structure |
| >pdb|4A4M|A Chain A, Crystal Structure Of The Light-Activated Constitutively Active N2c,M257y,D282c Rhodopsin Mutant In Complex With A Peptide Resembling The C-Terminus Of The Galpha-Protein Subunit (Gact) Length = 349 | Back alignment and structure |
| >pdb|2KS9|A Chain A, Solution Conformation Of Substance P In Water Complexed With Nk1r Length = 364 | Back alignment and structure |
| >pdb|4GRV|A Chain A, The Crystal Structure Of The Neurotensin Receptor Nts1 In Complex With Neurotensin (8-13) Length = 510 | Back alignment and structure |
| >pdb|3V2W|A Chain A, Crystal Structure Of A Lipid G Protein-Coupled Receptor At 3.35a Length = 520 | Back alignment and structure |
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 662 | |||
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 1e-112 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 2e-37 | |
| 3sn6_R | 514 | Lysozyme, beta-2 adrenergic receptor; seven transm | 1e-110 | |
| 3sn6_R | 514 | Lysozyme, beta-2 adrenergic receptor; seven transm | 6e-36 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 4e-90 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 2e-21 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 5e-21 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 1e-15 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 2e-89 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 1e-22 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 3e-22 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 4e-15 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 2e-87 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 2e-22 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 5e-22 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 1e-14 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 5e-87 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 3e-23 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 7e-23 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 1e-13 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 7e-82 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 1e-25 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 3e-25 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 3e-11 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 1e-80 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 7e-20 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 2e-19 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 1e-11 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 8e-61 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 9e-23 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 3e-22 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 4e-06 | |
| 2ks9_A | 364 | Substance-P receptor; water, autodock, NK1, neurop | 4e-40 | |
| 2ks9_A | 364 | Substance-P receptor; water, autodock, NK1, neurop | 2e-11 | |
| 2ks9_A | 364 | Substance-P receptor; water, autodock, NK1, neurop | 3e-11 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 3e-37 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 1e-08 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 2e-08 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 2e-04 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 5e-36 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 2e-06 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 4e-06 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 2e-35 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 4e-11 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 9e-11 | |
| 4ea3_A | 434 | Fusion protein of nociceptin receptor and cytochr; | 3e-34 | |
| 4ea3_A | 434 | Fusion protein of nociceptin receptor and cytochr; | 1e-12 | |
| 4ea3_A | 434 | Fusion protein of nociceptin receptor and cytochr; | 3e-12 | |
| 3odu_A | 502 | C-X-C chemokine receptor type 4, lysozyme chimera; | 6e-33 | |
| 3odu_A | 502 | C-X-C chemokine receptor type 4, lysozyme chimera; | 3e-06 | |
| 3odu_A | 502 | C-X-C chemokine receptor type 4, lysozyme chimera; | 6e-06 | |
| 1hll_A | 32 | Alpha-2A adrenergic receptor; helix-linker-helix, | 2e-14 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-04 |
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-112
Identities = 92/418 (22%), Positives = 154/418 (36%), Gaps = 47/418 (11%)
Query: 26 IDDDVVTYDFVSNFTLERWLELAQQRTLLVSTLSLFSLVTVFGNALVMIAVVRERYLHTS 85
+ F + ++ ++ +++ + GN LV AV L
Sbjct: 6 ALSYIFCLVFADYKDDDDGAPPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNV 65
Query: 86 TNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLNWCDSWRSLDVLFSTASILNLCV 145
TNYF++SLA AD VG++ +PF+ + + C ++ + +SI +L
Sbjct: 66 TNYFVVSLAAADIAVGVLAIPFAITIST---GFCAACHGCLFIACFVLVLTQSSIFSLLA 122
Query: 146 ISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEVPKNKCP 205
I++DRY AI PL Y ++ RA IAI W+ S I +L W + KN
Sbjct: 123 IAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQ 182
Query: 206 -------------FTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKVGTKQ 252
+ F+ +PLL+M+ Y +I+ AA Q L+ +
Sbjct: 183 GCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLADLEDNWET 242
Query: 253 VMSGSTSGEKELTLRIHRGGTDHRHMTL------------HHTPSDDVEMDNVMSGHNGI 300
+ EK + +P D +
Sbjct: 243 LNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILV 302
Query: 301 TRQVSNTRIIHKGHI----------------VKNFSLSRKLSKFAKEKKAAKTLGIVMGV 344
+ ++ ++G + L R S KE AAK+L I++G+
Sbjct: 303 GQIDDALKLANEGKVKEAQAAAEQLKTTRNAYIQKYLERARSTLQKEVHAAKSLAIIVGL 362
Query: 345 FIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFR 402
F +CWLP ++N + C C + + + L NS +NP IYA R+FR
Sbjct: 363 FALCWLPLHIINCFTFFCPDCSHA---PLWLMYLAIVLSHTNSVVNPFIYAYRIREFR 417
|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 | Back alignment and structure |
|---|
| >3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A Length = 514 | Back alignment and structure |
|---|
| >3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A Length = 514 | Back alignment and structure |
|---|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 | Back alignment and structure |
|---|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 | Back alignment and structure |
|---|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 | Back alignment and structure |
|---|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 | Back alignment and structure |
|---|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 | Back alignment and structure |
|---|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 | Back alignment and structure |
|---|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 | Back alignment and structure |
|---|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 | Back alignment and structure |
|---|
| >2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Length = 364 | Back alignment and structure |
|---|
| >2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Length = 364 | Back alignment and structure |
|---|
| >2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Length = 364 | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 | Back alignment and structure |
|---|
| >3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 | Back alignment and structure |
|---|
| >3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 | Back alignment and structure |
|---|
| >3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 | Back alignment and structure |
|---|
| >1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A Length = 32 | Back alignment and structure |
|---|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 662 | |||
| 4grv_A | 510 | Neurotensin receptor type 1, lysozyme chimera; G-p | 100.0 | |
| 3vw7_A | 484 | Proteinase-activated receptor 1, lysozyme; high re | 100.0 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 100.0 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 100.0 | |
| 3odu_A | 502 | C-X-C chemokine receptor type 4, lysozyme chimera; | 100.0 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 100.0 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 100.0 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 100.0 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 100.0 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 100.0 | |
| 2ks9_A | 364 | Substance-P receptor; water, autodock, NK1, neurop | 100.0 | |
| 2lnl_A | 296 | C-X-C chemokine receptor type 1; G protein coupled | 100.0 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 100.0 | |
| 4ea3_A | 434 | Fusion protein of nociceptin receptor and cytochr; | 100.0 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 100.0 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 100.0 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 100.0 | |
| 3sn6_R | 514 | Lysozyme, beta-2 adrenergic receptor; seven transm | 100.0 | |
| 4grv_A | 510 | Neurotensin receptor type 1, lysozyme chimera; G-p | 99.93 | |
| 3vw7_A | 484 | Proteinase-activated receptor 1, lysozyme; high re | 99.88 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 99.87 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 99.85 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 99.85 | |
| 3odu_A | 502 | C-X-C chemokine receptor type 4, lysozyme chimera; | 99.84 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 99.84 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 99.83 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 99.83 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 99.83 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 99.81 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 99.81 | |
| 3sn6_R | 514 | Lysozyme, beta-2 adrenergic receptor; seven transm | 99.8 | |
| 2lnl_A | 296 | C-X-C chemokine receptor type 1; G protein coupled | 99.8 | |
| 2ks9_A | 364 | Substance-P receptor; water, autodock, NK1, neurop | 99.8 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 99.79 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 99.79 | |
| 4ea3_A | 434 | Fusion protein of nociceptin receptor and cytochr; | 99.77 | |
| 2koe_A | 40 | Human cannabinoid receptor 1 - helix 7/8 peptide; | 98.5 | |
| 2koe_A | 40 | Human cannabinoid receptor 1 - helix 7/8 peptide; | 98.3 | |
| 2ki9_A | 33 | Cannabinoid receptor 2; GPCR, G-protein coupled re | 98.29 | |
| 1hll_A | 32 | Alpha-2A adrenergic receptor; helix-linker-helix, | 98.14 | |
| 2ki9_A | 33 | Cannabinoid receptor 2; GPCR, G-protein coupled re | 97.56 | |
| 2lot_A | 64 | Apelin receptor; membrane protein; NMR {Homo sapie | 96.11 | |
| 2ket_A | 27 | Cathelicidin-6; antimicrobial peptide, antibiotic, | 81.11 |
| >4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=401.68 Aligned_cols=364 Identities=19% Similarity=0.278 Sum_probs=236.1
Q ss_pred hHHHHHHHHHHHHHHHHHHhhHhhhhheecccccc---chhhHHHHHHHHHHHhhhhhcccHHHHHhhc-cccccccccc
Q psy5093 49 QQRTLLVSTLSLFSLVTVFGNALVMIAVVRERYLH---TSTNYFIMSLALADCLVGLVVMPFSALYELL-DHNWIFGLNW 124 (662)
Q Consensus 49 ~~~~i~~~~~~ii~i~gl~gN~~vi~~i~~~~~lr---~~~~~ll~~Lai~Dll~~l~~~p~~~~~~~~-~~~~~~~~~~ 124 (662)
..++++.++|.+++++|++||+++++++.++|++| +++|+|++|||++|++.+++.+|+.+...+. .+.|.+|+.+
T Consensus 30 ~~~v~~~~~~~~i~~~g~~gN~lvi~~i~~~~~~r~~~~~~n~~i~~La~aDll~~~~~~p~~~~~~~~~~~~w~~g~~~ 109 (510)
T 4grv_A 30 YSKVLVTAIYLALFVVGTVGNSVTLFTLARKKSLQSLQSTVHYHLGSLALSDLLILLLAMPVELYNFIWVHHPWAFGDAG 109 (510)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHTSCC----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCCSSCSSHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhhheeeecCCCCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCEEhhHHH
Confidence 34678888999999999999999999999887554 7889999999999999999999987776553 4679999999
Q ss_pred hhHHHHhhHHHHHHHHHHHHHHHHHHhhhhcCCCCCCccccchhhhHHHHHHHHHHHhhhhhHHHhhhccccCCCC----
Q psy5093 125 CDSWRSLDVLFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEVP---- 200 (662)
Q Consensus 125 C~~~~~~~~~~~~~s~~~l~~iaidRy~~I~~P~~y~~~~t~~~~~~~i~~~w~~s~~~~~~~~~~~~~~~~~~~~---- 200 (662)
|++..++..++..+|++++++||+|||++|++|++|+..++++++..+++++|++++++++|+++.+.........
T Consensus 110 C~~~~~~~~~~~~~S~~~l~~is~dRy~ai~~P~~~~~~~t~~~~~~~i~~~W~~s~~~~~p~~~~~~~~~~~~~~~~~~ 189 (510)
T 4grv_A 110 CRGYYFLRDACTYATALNVASLSVARYLAICHPFKAKTLMSRSRTKKFISAIWLASALLAIPMLFTMGLQNRSADGTHPG 189 (510)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSCCCCCCCCCCSCCHHHHHHHHHHHHHHHTTHHHHEEEEECSSSSCCGG
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHheEEEeccccccccccccccceeehHHHHHHHHHHHHHHHhhcccccccCCCCCC
Confidence 9999999999999999999999999999999999999999999999999999999999999999987655433222
Q ss_pred CCccccCCC----cchhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccCCcccc-----cCCCCCCccc-------
Q psy5093 201 KNKCPFTDS----KGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKVGTKQVM-----SGSTSGEKEL------- 264 (662)
Q Consensus 201 ~~~c~~~~~----~~~~~~~~~~~~~ip~~ii~~~y~~I~~~l~~~~~~~~~~~~~~~-----~~~~~~~~~~------- 264 (662)
...|..... ..|..+..++.|++|+++++++|.+|++.++++.+.....+.... ..........
T Consensus 190 ~~~c~~~~~~~~~~~~~~~~~~~~f~iP~~ii~~~Y~~I~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (510)
T 4grv_A 190 GLVCTPIVDTATVKVVIQVNTFMSFLFPMLVISILNTVIANKLTVMVNIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLT 269 (510)
T ss_dssp GEEEEECSCHHHHHHHHHHHHHHHTHHHHHHHHHHHHHHHHHHHTSCTHHHHHHHHTCCEEEEEECTTSCEEEETTEECC
T ss_pred ccccccccccchhhhhhhhhhhHHHhhhHHHHHHHHHHHHHHHHHHhhhhhhhccccccccccccccccccccccccccC
Confidence 223433332 235556677889999999999999999999875443221110000 0000000000
Q ss_pred ---eeeeccCCCCCCCCccCCCCCCcccccc------------ccc---------cCC----------------------
Q psy5093 265 ---TLRIHRGGTDHRHMTLHHTPSDDVEMDN------------VMS---------GHN---------------------- 298 (662)
Q Consensus 265 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~---------~~~---------------------- 298 (662)
.........+..............+.+. ... ...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (510)
T 4grv_A 270 KSPSLNAAKSELDKAIGRNTNGVITKDEAEKLFNQDVDAAVRGILRNAKLKPVYDSLDAVRRAALINMVFQMGETGVAGF 349 (510)
T ss_dssp CSSSHHHHHHSCCC---CCCTTBCCHHHHHHHHHHHHHHHHHHHHHCTTTHHHHHHSCSHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCCCCCccccccCcCCCCCCCCcccCCccccccCCCCcccccccccCCCCCCCcCccccccccccCCccccCCCCCCCCC
Confidence 0000000000000000000000000000 000 000
Q ss_pred ---------Ccccccccccccccc-------------ccccccccccchhhHHhhhhhHHHHHHHHHHHHhhhhhHHHHH
Q psy5093 299 ---------GITRQVSNTRIIHKG-------------HIVKNFSLSRKLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVN 356 (662)
Q Consensus 299 ---------~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~f~i~~~P~~i~~ 356 (662)
.............+. ..+.....+++++..++|+|++||+++++++|++||+|++++.
T Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~erk~~k~L~iVv~~F~iCWlPf~i~~ 429 (510)
T 4grv_A 350 TNSLRMLNNKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYGSGSVQALRHGVLVARAVVIAFVVCWLPYHVRR 429 (510)
T ss_dssp HHHHHHHTTTCHHHHHHHHHSSCSCCSSHHHHHHHHHHHHHSSSGGGTTSTTTHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CccccccccCCCcccccccccccccccCCccccccccccccccchhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 000000000000000 0000111223334456789999999999999999999999999
Q ss_pred HHHHhhccccCCC---chhHHHHHHHHHHHHhhccccchhhhhcChhHHHHHHHhcccC
Q psy5093 357 LLSAVCTKCFWSE---QDEELISAVVTWLGWINSGMNPVIYACWSRDFRSKEKILNHKI 412 (662)
Q Consensus 357 ~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~ns~~nP~IY~~~~~~fR~~~~~l~~~~ 412 (662)
++..+.++..... ....++..++.+|+|+||++||+||+++|++||+++|++++++
T Consensus 430 l~~~~~~~~~~~~~~~~~~~~~~~~~~~L~Y~NS~iNPiIY~~~n~~FR~aFk~iL~C~ 488 (510)
T 4grv_A 430 LMFCYISDEQWTTFLFDFYHYFYMLTNALAYASSAINPILYNLVSANFRQVFLSTLACL 488 (510)
T ss_dssp HHHHTTTTTCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSCCCCC--------
T ss_pred HHHHHcCcccCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHHhhc
Confidence 9987765433221 1234566788999999999999999999999999999987543
|
| >3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* | Back alignment and structure |
|---|
| >3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens} | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} | Back alignment and structure |
|---|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* | Back alignment and structure |
|---|
| >2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A | Back alignment and structure |
|---|
| >2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... | Back alignment and structure |
|---|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* | Back alignment and structure |
|---|
| >3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A* | Back alignment and structure |
|---|
| >4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus} | Back alignment and structure |
|---|
| >3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* | Back alignment and structure |
|---|
| >3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} | Back alignment and structure |
|---|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens} | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* | Back alignment and structure |
|---|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A | Back alignment and structure |
|---|
| >3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A* | Back alignment and structure |
|---|
| >2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... | Back alignment and structure |
|---|
| >2koe_A Human cannabinoid receptor 1 - helix 7/8 peptide; GPCR, HCB1, membrane protein, signaling protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >2koe_A Human cannabinoid receptor 1 - helix 7/8 peptide; GPCR, HCB1, membrane protein, signaling protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >2ki9_A Cannabinoid receptor 2; GPCR, G-protein coupled receptor, membrane protein; NMR {Synthetic} | Back alignment and structure |
|---|
| >1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A | Back alignment and structure |
|---|
| >2ki9_A Cannabinoid receptor 2; GPCR, G-protein coupled receptor, membrane protein; NMR {Synthetic} | Back alignment and structure |
|---|
| >2lot_A Apelin receptor; membrane protein; NMR {Homo sapiens} PDB: 2lou_A 2lov_A 2low_A | Back alignment and structure |
|---|
| >2ket_A Cathelicidin-6; antimicrobial peptide, antibiotic, antimicrobial, fungicide, pyrrolidone carboxylic acid, secreted; NMR {Bos taurus} | Back alignment and structure |
|---|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 662 | ||||
| d1u19a_ | 348 | f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: | 2e-18 | |
| d1u19a_ | 348 | f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: | 3e-09 | |
| d1u19a_ | 348 | f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: | 8e-09 |
| >d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Length = 348 | Back information, alignment and structure |
|---|
class: Membrane and cell surface proteins and peptides fold: Family A G protein-coupled receptor-like superfamily: Family A G protein-coupled receptor-like family: Rhodopsin-like domain: Rhodopsin species: Cow (Bos taurus) [TaxId: 9913]
Score = 84.6 bits (208), Expect = 2e-18
Identities = 41/232 (17%), Positives = 91/232 (39%), Gaps = 16/232 (6%)
Query: 13 DFFSNSSNWTYIDIDDDVVTYDFVSNFTLERWLELAQQRTLLVSTLSLFSLVTVFGNALV 72
+F+ SN T + ++ + E W Q ++L + + L ++ N L
Sbjct: 8 NFYVPFSNKTGVVRS----PFEAPQYYLAEPW-----QFSMLAAYMFLLIMLGFPINFLT 58
Query: 73 MIAVVRERYLHTSTNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLNWCDSWRSLD 132
+ V+ + L T NY +++LA+AD + + L ++FG C+
Sbjct: 59 LYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYT-SLHGYFVFGPTGCNLEGFFA 117
Query: 133 VLFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWR 192
L ++ +L V++++RY + P++ + + P + W R
Sbjct: 118 TLGGEIALWSLVVLAIERYVVVCKPMSNFRFGENHAIMGVAFTWVMALACAAPPLVGWSR 177
Query: 193 AVRN------EEVPKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRA 238
+ T+++ ++I+ + F +PL+V+ F Y ++
Sbjct: 178 YIPEGMQCSCGIDYYTPHEETNNESFVIYMFVVHFIIPLIVIFFCYGQLVFT 229
|
| >d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Length = 348 | Back information, alignment and structure |
|---|
| >d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Length = 348 | Back information, alignment and structure |
|---|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 662 | |||
| d1u19a_ | 348 | Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1u19a_ | 348 | Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | 99.73 |
| >d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Membrane and cell surface proteins and peptides fold: Family A G protein-coupled receptor-like superfamily: Family A G protein-coupled receptor-like family: Rhodopsin-like domain: Rhodopsin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.6e-35 Score=295.91 Aligned_cols=285 Identities=19% Similarity=0.347 Sum_probs=225.1
Q ss_pred HhHHHHHHHHHHHHHHHHHHhhHhhhhheeccccccchhhHHHHHHHHHHHhhhhhcccHHHHHhhccccccccccchhH
Q psy5093 48 AQQRTLLVSTLSLFSLVTVFGNALVMIAVVRERYLHTSTNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLNWCDS 127 (662)
Q Consensus 48 ~~~~~i~~~~~~ii~i~gl~gN~~vi~~i~~~~~lr~~~~~ll~~Lai~Dll~~l~~~p~~~~~~~~~~~~~~~~~~C~~ 127 (662)
++...++++++.+++++|++||+++++++.++|++|++.|++++|||++|++.++..+|..+.... .+.|..+...|+.
T Consensus 34 ~~~~~~~~~~~~ii~v~gi~gN~lvi~vi~~~k~lr~~~~~~l~nLaiaDll~~~~~~~~~~~~~~-~~~~~~~~~~c~~ 112 (348)
T d1u19a_ 34 PWQFSMLAAYMFLLIMLGFPINFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSL-HGYFVFGPTGCNL 112 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSTTCCSHHHHHHHHHHHHHHHHHHHTHHHHHHHHH-HTSCTTHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHeehhhhccCCCCCHhHHHHHHHHHHHHHHHHHHHHHhhhhhc-cCccccCchhhhh
Confidence 445678889999999999999999999999999999999999999999999998888886555444 5678888999999
Q ss_pred HHHhhHHHHHHHHHHHHHHHHHHhhhhcCCCCCCccccchhhhHHHHHHHHHHHhhhhhHHHhhhccccCCCCCCccccC
Q psy5093 128 WRSLDVLFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEVPKNKCPFT 207 (662)
Q Consensus 128 ~~~~~~~~~~~s~~~l~~iaidRy~~I~~P~~y~~~~t~~~~~~~i~~~w~~s~~~~~~~~~~~~~~~~~~~~~~~c~~~ 207 (662)
..++..++..++.++++++++|||++|++|++|+. .++++....++.+|.+++++..++.+.......... ...|...
T Consensus 113 ~~~~~~~~~~~s~~~l~~is~~R~~~i~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 190 (348)
T d1u19a_ 113 EGFFATLGGEIALWSLVVLAIERYVVVCKPMSNFR-FGENHAIMGVAFTWVMALACAAPPLVGWSRYIPEGM-QCSCGID 190 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHTCCSSSCC-CCHHHHHHHHHHHHHHHHHHHSGGGTTSSCCEEETT-TTEEECC
T ss_pred hhhccccceeeecchhhhhhcccceeeeccccccc-cccccccccceeeehhhhheecccccccceeccCCc-ccccccc
Confidence 99999999999999999999999999999999765 467777788888899999988888877655433332 2222111
Q ss_pred --------CCcchhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccCCcccccCCCCCCccceeeeccCCCCCCCCc
Q psy5093 208 --------DSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKVGTKQVMSGSTSGEKELTLRIHRGGTDHRHMT 279 (662)
Q Consensus 208 --------~~~~~~~~~~~~~~~ip~~ii~~~y~~I~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (662)
....+..+...+.+++|+++++++|.++.+.++++.++.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~ip~~i~~~~y~~i~~~~~~~~~~~--------------------------------- 237 (348)
T d1u19a_ 191 YYTPHEETNNESFVIYMFVVHFIIPLIVIFFCYGQLVFTVKEAAAQQ--------------------------------- 237 (348)
T ss_dssp CSCCCGGGTHHHHHHHHHHHTTHHHHHHHHHHHTTTTTSSCSCCCSS---------------------------------
T ss_pred cccccccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhhccccccc---------------------------------
Confidence 122244555666778899999999999877654332211
Q ss_pred cCCCCCCccccccccccCCCccccccccccccccccccccccccchhhHHhhhhhHHHHHHHHHHHHhhhhhHHHHHHHH
Q psy5093 280 LHHTPSDDVEMDNVMSGHNGITRQVSNTRIIHKGHIVKNFSLSRKLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLS 359 (662)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~f~i~~~P~~i~~~~~ 359 (662)
+....+.++++|+++++++++++|++||+|+.+..++.
T Consensus 238 ------------------------------------------~~~~~~~~~~~~~~~~~~~i~~~f~~~~~P~~i~~~~~ 275 (348)
T d1u19a_ 238 ------------------------------------------QESATTQKAEKEVTRMVIIMVIAFLICWLPYAGVAFYI 275 (348)
T ss_dssp ------------------------------------------CSSSHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------chhhhhHHHHhhHhheEEEeehHHHHHhhHHHhhhhee
Confidence 01112334789999999999999999999999988877
Q ss_pred HhhccccCCCchhHHHHHHHHHHHHhhccccchhhhhcChhHHHHHHHhcccCCc
Q psy5093 360 AVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFRSKEKILNHKISP 414 (662)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~l~~~ns~~nP~IY~~~~~~fR~~~~~l~~~~~~ 414 (662)
...+. .........+..++.++|+++||+||+++|++||+++++++|+.++
T Consensus 276 ~~~~~----~~~~~~~~~~~~~l~~~ns~iNPiIY~~~~~~fR~~~~~~l~c~~~ 326 (348)
T d1u19a_ 276 FTHQG----SDFGPIFMTIPAFFAKTSAVYNPVIYIMMNKQFRNCMVTTLCCGKN 326 (348)
T ss_dssp HHTTT----SCCCHHHHHHHHHHGGGGGTHHHHHHHHTCHHHHHHHHHHHTSSCC
T ss_pred eccCC----ccccHHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHhCCCCC
Confidence 66543 3334566778889999999999999999999999999988764443
|
| >d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|